| 1 |
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach. ( 30828796
)
|
Lieberman L...International Collaboration for Transfusion Medicine Guidelines (ICTMG)
|
2019 |
| 2 |
Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study. ( 29119564
)
|
Refsum E....Westgren M.
|
2018 |
| 3 |
Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets. ( 29306729
)
|
Refsum E....HAPglund P.
|
2018 |
| 4 |
Perinatal Outcome and Long-Term Neurodevelopment after Intracranial Haemorrhage due to Fetal and Neonatal Alloimmune Thrombocytopenia. ( 29730660
)
|
Winkelhorst D....van Klink J.M.M.
|
2018 |
| 5 |
Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program. ( 29412452
)
|
Kjaer M....Husebekk A.
|
2018 |
| 6 |
Implication of antibodies against human leukocyte antigen in simultaneous presentation of fetal and neonatal alloimmune thrombocytopenia and neutropenia. ( 30318177
)
|
Gimferrer I...Chabra S
|
2018 |
| 7 |
Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH. ( 30382606
)
|
Petermann R...Subcommittee on Platelet Immunology
|
2018 |
| 8 |
Fetal and neonatal alloimmune thrombocytopenia. ( 30848151
)
|
Neumann A...Calda P
|
2018 |
| 9 |
Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies. ( 28644735
)
|
Winkelhorst D....Lopriore E.
|
2017 |
| 10 |
Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities. ( 28458583
)
|
Tiller H....Skogen B.
|
2017 |
| 11 |
Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. ( 28130210
)
|
Winkelhorst D....Ryan G.
|
2017 |
| 12 |
Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia. ( 27748520
)
|
Sainio S....Haimila K.
|
2017 |
| 13 |
Fetal and neonatal alloimmune thrombocytopenia. ( 26810319
)
|
Zdravic D....Ni H.
|
2016 |
| 14 |
Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage. ( 26469867
)
|
Delbos F....Kaplan C.
|
2016 |
| 15 |
Fetal and Neonatal Alloimmune Thrombocytopenia: Management and Outcome of a Large International Retrospective Cohort. ( 27728915
)
|
Kamphuis M.M....Oepkes D.
|
2016 |
| 16 |
Lower-dose intravenous immunoglobulins for the treatment of fetal and neonatal alloimmune thrombocytopenia: a cohort study. ( 27383293
)
|
Kamphuis M....Oepkes D.
|
2016 |
| 17 |
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia. ( 27611703
)
|
Lakkaraja M....Bussel J.B.
|
2016 |
| 18 |
HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia. ( 28019029
)
|
Wienzek-Lischka S....Bein G.
|
2016 |
| 19 |
Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia. ( 27627660
)
|
Weng Y.J....Burnouf T.
|
2016 |
| 20 |
What do we know about intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia? ( 26756707
)
|
Bussel J.B.
|
2016 |
| 21 |
Placental histological lesions in fetal and neonatal alloimmune thrombocytopenia: A retrospective cohort study of 21 cases. ( 27871460
)
|
Dubruc E....Allias F.
|
2016 |
| 22 |
Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia. ( 26388194
)
|
Wihadmadyatami H....Santoso S.
|
2015 |
| 23 |
Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial. ( 25896635
)
|
Paridaans N.P....Oepkes D.
|
2015 |
| 24 |
Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia. ( 28345015
)
|
Vadasz B....Ni H.
|
2015 |
| 25 |
Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia. ( 26344048
)
|
Curtis B.R.
|
2015 |
| 26 |
How do we treat fetal and neonatal alloimmune thrombocytopenia? ( 24773309
)
|
Bertrand G....Kaplan C.
|
2014 |
| 27 |
Core fucosylation and IgG function in NAIT. ( 24458274
)
|
Aster RH
|
2014 |
| 28 |
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia. ( 24067944
)
|
Li C....Ni H.
|
2013 |
| 29 |
Fetal and neonatal alloimmune thrombocytopenia. ( 23687553
)
|
Espinoza J.P....Illanes S.E.
|
2013 |
| 30 |
Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry. ( 23524102
)
|
Tiller H....Westgren M.
|
2013 |
| 31 |
The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia. ( 23278334
)
|
Bakchoul T....Kaplan C.
|
2013 |
| 32 |
Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia. ( 23344412
)
|
Rink B.D....O'Shaughnessy R.
|
2013 |
| 33 |
Would it be possible to prevent HPA-1a alloimmunization to reduce the incidence of fetal and neonatal alloimmune thrombocytopenia? ( 22780891
)
|
Kumpel B.M.
|
2012 |
| 34 |
A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital. ( 22510050
)
|
Cook T.J....Dickinson J.E.
|
2012 |
| 35 |
Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. ( 22251227
)
|
Tiller H....Ni H.
|
2012 |
| 36 |
Fetal and neonatal alloimmune thrombocytopenia. ( 23482913
)
|
Constantinescu S....Vladareanu P.R.
|
2012 |
| 37 |
Delayed diagnosis of fetal and neonatal alloimmune thrombocytopenia: a cause of perinatal mortality and morbidity. ( 23078538
)
|
Madani K....Oepkes D.
|
2012 |
| 38 |
Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. ( 22015886
)
|
Pacheco L.D....Saade G.R.
|
2011 |
| 39 |
Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. ( 21618560
)
|
Kamphuis M.M....Oepkes D.
|
2011 |
| 40 |
The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia. ( 21708486
)
|
Stuge T.B....Bessos H.
|
2011 |
| 41 |
Fetal and neonatal alloimmune thrombocytopenia: harvesting the evidence to develop a clinical approach to management. ( 20700860
)
|
Symington A...Paes B
|
2011 |
| 42 |
A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia. ( 21332723
)
|
Kroll H...Santoso S
|
2011 |
| 43 |
A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry. ( 21631435
)
|
McQuilten ZK...Cole S
|
2011 |
| 44 |
Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. ( 21083473
)
|
Skogen B...Husebekk A
|
2010 |
| 45 |
Fetal and neonatal alloimmune thrombocytopenia. ( 17936686
)
|
van den Akker ES...Oepkes D
|
2008 |
| 46 |
Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. ( 17981381
)
|
Bussel JB...Primiani A
|
2008 |
| 47 |
Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT). ( 18945639
)
|
Bessos H...Urbaniak SJ
|
2008 |
| 48 |
Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG. ( 17177068
)
|
te Pas AB...Walther FJ
|
2007 |
| 49 |
Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. ( 17309545
)
|
van den Akker ES...Kanhai HH
|
2007 |
| 50 |
A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. ( 16317099
)
|
Ni H....Freedman J.
|
2006 |
